In the realm of cardiovascular health, precise monitoring and early detection of potential issues are crucial for maintaining overall well-being. Traditional blood pressure measurements taken at the arm often fail to provide a complete picture of cardiovascular health, potentially overlooking critical indicators of arterial function.

SphygmoCor® technology, developed by Cardiex, has revolutionized cardiovascular assessment by offering unparalleled insights into arterial function. This advanced technology provides a detailed analysis of central arterial pressure, arterial stiffness, and multiple other arterial biomarkers not available from traditional blood pressure devices. For over 25 years, these metrics have enabled healthcare providers and researchers to gain a more accurate understanding of cardiovascular health, facilitating early detection and intervention to improve heart health. CONNEQT Health, a subsidiary of Cardiex, leverages this innovative technology to offer consumers accessible, cutting-edge health monitoring solutions at home with the world’s most advanced personal arterial health monitor, the CONNEQT Pulse.

What is SphygmoCor Technology? (si–fig-ma-core)

SphygmoCor technology is an advanced, non-invasive system designed to provide a comprehensive analysis of central blood pressure and arterial stiffness. Unlike traditional arm-based blood pressure measurements, which offer limited insight into the true pressures experienced by the heart and the major organs and arteries, SphygmoCor delivers a detailed evaluation of how well your cardiovascular system is functioning overall. This is crucial for understanding the true state of your cardiovascular health and risk of major organ disease.

This innovative, patented technology captures pressure signals from an artery in the arm, such as the brachial artery at the upper arm, radial artery at the wrist, or digital artery at the finger. It then uses sophisticated algorithms to derive key cardiovascular metrics from the aorta, the body’s largest artery that carries blood from the heart to the circulatory system. The procedure is quick, painless, and delivers highly accurate results, making it an invaluable tool for both clinical and home use.

“New methods that assess arterial pressure and flow dynamics, beyond focus on conventional upper-arm blood pressure, are needed.”

Lancet Commission on Hypertension

A Breakthrough in Cardiovascular Health Monitoring

SphygmoCor is a well-validated tool backed by extensive research. To date, SphygmoCor has been referenced in over 2,400 research publications, supporting countless studies across health conditions ranging from hypertension and heart failure to cognitive decline and sexual health. This wealth of research has established SphygmoCor as the gold standard in arterial health assessment, trusted by researchers and clinicians worldwide. By offering reliable data on central arterial pressure and arterial stiffness, SphygmoCor has contributed significantly to our understanding of cardiovascular health and disease.

SphygmoCor provides several key biomarkers that offer comprehensive insights into cardiovascular health. One of these is Central Blood Pressure (CBP), which measures the pressure in the aorta, offering a more accurate prediction of cardiovascular risk than traditional brachial blood pressure. Understanding CBP is crucial for assessing the true burden on the heart and major arteries. Another critical metric is the Augmentation Index (AIx), which assesses the elasticity of the arteries and the efficiency of blood circulation. Elevated AIx values signify increased arterial stiffness, potentially impeding blood flow and heightening the risk of cardiovascular complications. Subendocardial Viability Ratio (SEVR) is also measured, an indicator of the balance between oxygen supply and demand in the heart. Lower SEVR values can indicate that the heart is under strain and not receiving enough oxygen, potentially leading to an increased risk of cardiovascular events.

These metrics, combined with the vast body of research supporting SphygmoCor, provide a comprehensive tool for assessing and managing cardiovascular health. Whether used in clinical settings or at home, SphygmoCor enables early detection and personalized treatment strategies, playing a crucial role in advancing our understanding of heart health and improving health outcomes. Its ability to deliver detailed, accurate, and reliable data on arterial health makes it an invaluable asset in the fight against cardiovascular disease.

Bringing Cutting-Edge Health Monitoring to The Home

The CONNEQT Pulse, the world’s most advanced personal arterial health monitor, integrates SphygmoCor technology into a user-friendly device empowering everyone to take control of their cardiovascular health from the comfort of their own homes.

For individuals looking to improve and sustain their health, the CONNEQT Pulse allows for the early detection of disease onset and progression by monitoring arterial stiffness. Early detection enables timely medical intervention and better management of health risks before they become severe. The detailed insights into arterial health also help healthcare providers tailor treatments specifically to the needs of their patients. Accurate monitoring of arterial health leads to better management of cardiovascular conditions, potentially reducing the risk of heart attacks, strokes, and other serious events.

This personalized approach to health monitoring ensures that each individual receives care tailored to their unique cardiovascular profile. By bringing advanced arterial health monitoring into the home, the CONNEQT Pulse makes it easier than ever to stay proactive about heart health. With reliable, detailed data at your fingertips, you can make informed decisions about your lifestyle and healthcare, ultimately enhancing your longevity and healthspan.

Sources